View in EDS

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED].

Saved in:
Bibliographic Details
Title: Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED].
Authors: Goodin DS, Frohman EM, Garmany GP Jr, Halper J, Likosky WH, Lublin FD, Silberberg DH, Stuart WH, van den Noort S
Corporate Authors: Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines
Source: Neurology [Neurology] 2002 Jan 22; Vol. 58 (2), pp. 169-78.
Publication Type: Guideline; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print Cited Medium: Print ISSN: 0028-3878 (Print) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 11805241
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED].
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Goodin+DS%22">Goodin DS</searchLink><br /><searchLink fieldCode="AU" term="%22Frohman+EM%22">Frohman EM</searchLink><br /><searchLink fieldCode="AU" term="%22Garmany+GP+Jr%22">Garmany GP Jr</searchLink><br /><searchLink fieldCode="AU" term="%22Halper+J%22">Halper J</searchLink><br /><searchLink fieldCode="AU" term="%22Likosky+WH%22">Likosky WH</searchLink><br /><searchLink fieldCode="AU" term="%22Lublin+FD%22">Lublin FD</searchLink><br /><searchLink fieldCode="AU" term="%22Silberberg+DH%22">Silberberg DH</searchLink><br /><searchLink fieldCode="AU" term="%22Stuart+WH%22">Stuart WH</searchLink><br /><searchLink fieldCode="AU" term="%22van+den+Noort+S%22">van den Noort S</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Therapeutics+and+Technology+Assessment+Subcommittee+of+the+American+Academy+of+Neurology+and+the+MS+Council+for+Clinical+Practice+Guidelines%22">Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220401060%22">Neurology</searchLink> [Neurology] 2002 Jan 22; Vol. 58 (2), pp. 169-78.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Guideline; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lippincott+Williams+%26+Wilkins%22">Lippincott Williams & Wilkins </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0401060 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0028-3878 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200283878%22">00283878 </searchLink><i>NLM ISO Abbreviation: </i>Neurology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=11805241
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1212/wnl.58.2.169
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 169
    Titles:
      – TitleFull: Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines [RETIRED].
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Goodin DS
      – PersonEntity:
          Name:
            NameFull: Frohman EM
      – PersonEntity:
          Name:
            NameFull: Garmany GP Jr
      – PersonEntity:
          Name:
            NameFull: Halper J
      – PersonEntity:
          Name:
            NameFull: Likosky WH
      – PersonEntity:
          Name:
            NameFull: Lublin FD
      – PersonEntity:
          Name:
            NameFull: Silberberg DH
      – PersonEntity:
          Name:
            NameFull: Stuart WH
      – PersonEntity:
          Name:
            NameFull: van den Noort S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 01
              Text: 2002 Jan 22
              Type: published
              Y: 2002
          Identifiers:
            – Type: issn-print
              Value: 0028-3878
          Numbering:
            – Type: volume
              Value: 58
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Neurology
              Type: main
ResultId 1